Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
Drugs that cause pulmonary toxicity.

The Medical letter on drugs and therapeutics

[No authors listed]
PMID: 2402221
Med Lett Drugs Ther. 1990 Sep 21;32(827):88-90.

No abstract available.

Cite
Drugs that cause pulmonary toxicity. Med Lett Drugs Ther. 1990;32(827):88-90
(1990). Drugs that cause pulmonary toxicity. The Medical letter on drugs and therapeutics, 32(827), 88-90.
"Drugs that cause pulmonary toxicity." The Medical letter on drugs and therapeutics vol. 32,827 (1990): 88-90.
Drugs that cause pulmonary toxicity. Med Lett Drugs Ther. 1990 Sep 21;32(827):88-90. PMID: 2402221.
Copy Download .nbib Format: NLM
The Heart-Lung Dilemma in COPD: A Tale of Two Cities.

Archivos de bronconeumologia

López-Campos JL, Carrasco Hernández L, Quintana Gallego E.
PMID: 30471917
Arch Bronconeumol (Engl Ed). 2019 Apr;55(4):185-186. doi: 10.1016/j.arbres.2018.10.006. Epub 2018 Nov 22.

No abstract available.

Cite
López-Campos JL, Carrasco Hernández L, Quintana Gallego E. El dilema entre el pulmón y el corazón en EPOC: historia de dos ciudades. The Heart-Lung Dilemma in COPD: A Tale of Two Cities. Arch Bronconeumol (Engl Ed). 2018;55(4):185-186doi: 10.1016/j.arbres.2018.10.006.
López-Campos, J. L., Carrasco Hernández, L., & Quintana Gallego, E. (2019). El dilema entre el pulmón y el corazón en EPOC: historia de dos ciudades. The Heart-Lung Dilemma in COPD: A Tale of Two Cities. Archivos de bronconeumologia, 55(4), 185-186. https://doi.org/10.1016/j.arbres.2018.10.006
López-Campos, José Luis, et al. "El dilema entre el pulmón y el corazón en EPOC: historia de dos ciudades." The Heart-Lung Dilemma in COPD: A Tale of Two Cities. Archivos de bronconeumologia vol. 55,4 (2019): 185-186. doi: https://doi.org/10.1016/j.arbres.2018.10.006
López-Campos JL, Carrasco Hernández L, Quintana Gallego E. El dilema entre el pulmón y el corazón en EPOC: historia de dos ciudades. The Heart-Lung Dilemma in COPD: A Tale of Two Cities. Arch Bronconeumol (Engl Ed). 2019 Apr;55(4):185-186. doi: 10.1016/j.arbres.2018.10.006. Epub 2018 Nov 22. Spanish. PMID: 30471917.
Copy Download .nbib Format: NLM
[Experimental pneumoconstriction & pneumodilation].

Revue medicale de Nancy

DAUTREBANDE L.
PMID: 13454236
Rev Med Nancy. 1957 Jul;82:743-55; discussion, 756-60.

No abstract available.

Cite
DAUTREBANDE L. Pneumoconstriction et pneumodilatation expérimentales. [Experimental pneumoconstriction & pneumodilation]. Rev Med Nancy. 1957;82:743-55; discussion, 756-60
DAUTREBANDE, L. (1957). Pneumoconstriction et pneumodilatation expérimentales. [Experimental pneumoconstriction & pneumodilation]. Revue medicale de Nancy, 82743-55; discussion, 756-60.
DAUTREBANDE, L. "Pneumoconstriction et pneumodilatation expérimentales." [Experimental pneumoconstriction & pneumodilation]. Revue medicale de Nancy vol. 82 (1957): 743-55; discussion, 756-60.
DAUTREBANDE L. Pneumoconstriction et pneumodilatation expérimentales. [Experimental pneumoconstriction & pneumodilation]. Rev Med Nancy. 1957 Jul;82:743-55; discussion, 756-60. French. PMID: 13454236.
Copy Download .nbib Format: NLM
Nanoparticles and children's lungs: is there a need for caution?.

Paediatric respiratory reviews

Sly PD, Schüepp K.
PMID: 22475250
Paediatr Respir Rev. 2012 Jun;13(2):71-2. doi: 10.1016/j.prrv.2011.07.005. Epub 2011 Nov 30.

No abstract available.

Cite
Sly PD, Schüepp K. Nanoparticles and children's lungs: is there a need for caution?. Paediatr Respir Rev. 2011;13(2):71-2doi: 10.1016/j.prrv.2011.07.005.
Sly, P. D., & Schüepp, K. (2012). Nanoparticles and children's lungs: is there a need for caution?. Paediatric respiratory reviews, 13(2), 71-2. https://doi.org/10.1016/j.prrv.2011.07.005
Sly, Peter D, and Schüepp, Karen. "Nanoparticles and children's lungs: is there a need for caution?." Paediatric respiratory reviews vol. 13,2 (2012): 71-2. doi: https://doi.org/10.1016/j.prrv.2011.07.005
Sly PD, Schüepp K. Nanoparticles and children's lungs: is there a need for caution?. Paediatr Respir Rev. 2012 Jun;13(2):71-2. doi: 10.1016/j.prrv.2011.07.005. Epub 2011 Nov 30. PMID: 22475250.
Copy Download .nbib Format: NLM
Nanoparticles and children's lungs: is there a need for caution?.

Paediatric respiratory reviews

Sly PD, Schüepp K.
PMID: 22475250
Paediatr Respir Rev. 2012 Jun;13(2):71-2. doi: 10.1016/j.prrv.2011.07.005. Epub 2011 Nov 30.

No abstract available.

Cite
Sly PD, Schüepp K. Nanoparticles and children's lungs: is there a need for caution?. Paediatr Respir Rev. 2011;13(2):71-2doi: 10.1016/j.prrv.2011.07.005.
Sly, P. D., & Schüepp, K. (2012). Nanoparticles and children's lungs: is there a need for caution?. Paediatric respiratory reviews, 13(2), 71-2. https://doi.org/10.1016/j.prrv.2011.07.005
Sly, Peter D, and Schüepp, Karen. "Nanoparticles and children's lungs: is there a need for caution?." Paediatric respiratory reviews vol. 13,2 (2012): 71-2. doi: https://doi.org/10.1016/j.prrv.2011.07.005
Sly PD, Schüepp K. Nanoparticles and children's lungs: is there a need for caution?. Paediatr Respir Rev. 2012 Jun;13(2):71-2. doi: 10.1016/j.prrv.2011.07.005. Epub 2011 Nov 30. PMID: 22475250.
Copy Download .nbib Format: NLM
Risk assessment studies of nanomaterials in Japan and other countries.

Asian Pacific journal of cancer prevention : APJCP

Tsuda H.
PMID: 20593919
Asian Pac J Cancer Prev. 2010;11(1):13-4.

Recent developments in nanoparticle (NP) technology and their commercial production have raised concern regarding NP risk to health and the environment. The toxicological characteristics of NP may not be similar to that observed in pre-NP materials because of the...

Cite
Tsuda H. Risk assessment studies of nanomaterials in Japan and other countries. Asian Pac J Cancer Prev. 2010;11(1):13-4
Tsuda, H. (2010). Risk assessment studies of nanomaterials in Japan and other countries. Asian Pacific journal of cancer prevention : APJCP, 11(1), 13-4.
Tsuda, Hiroyuki. "Risk assessment studies of nanomaterials in Japan and other countries." Asian Pacific journal of cancer prevention : APJCP vol. 11,1 (2010): 13-4.
Tsuda H. Risk assessment studies of nanomaterials in Japan and other countries. Asian Pac J Cancer Prev. 2010;11(1):13-4. PMID: 20593919.
Copy Download .nbib Format: NLM
Nanotoxicity: challenging the myth of nano-specific toxicity.

Current opinion in biotechnology

Donaldson K, Poland CA.
PMID: 23768801
Curr Opin Biotechnol. 2013 Aug;24(4):724-34. doi: 10.1016/j.copbio.2013.05.003. Epub 2013 Jun 11.

The analysis of nanoparticle (NP) hazard is currently a major research pre-occupation for particle toxicologists since there is a pressing requirement for a comprehensive understanding of nanoparticle hazard because of the wide spectrum of NP varying in composition, shape...

Cite
Donaldson K, Poland CA. Nanotoxicity: challenging the myth of nano-specific toxicity. Curr Opin Biotechnol. 2013;24(4):724-34doi: 10.1016/j.copbio.2013.05.003.
Donaldson, K., & Poland, C. A. (2013). Nanotoxicity: challenging the myth of nano-specific toxicity. Current opinion in biotechnology, 24(4), 724-34. https://doi.org/10.1016/j.copbio.2013.05.003
Donaldson, Ken, and Poland, Craig A. "Nanotoxicity: challenging the myth of nano-specific toxicity." Current opinion in biotechnology vol. 24,4 (2013): 724-34. doi: https://doi.org/10.1016/j.copbio.2013.05.003
Donaldson K, Poland CA. Nanotoxicity: challenging the myth of nano-specific toxicity. Curr Opin Biotechnol. 2013 Aug;24(4):724-34. doi: 10.1016/j.copbio.2013.05.003. Epub 2013 Jun 11. PMID: 23768801.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries